Niche Medical Marketing: Why Regenerative Medicine Practices Cannot Use Generic Agency Playbooks
Most marketing agencies are good at what they do. The problem is that what they do was built for businesses that are nothing like a regenerative medicine clinic. The same playbook that grows a dental office or a med spa can stall a regen practice, or worse, get its ad accounts shut down. This post […]
Stem Cell Content Marketing: How To Build Authority Without Triggering FDA Or FTC Risk
Stem cell clinics have some of the highest patient demand in medicine and some of the tightest marketing rules. You want content that brings in search traffic and patient inquiries. You also cannot afford a piece of content that crosses an FDA or FTC line. This guide shows how to build authority and traffic with […]
Regenerative Medicine vs. Insurance-Based Practice: The Real Business Case for Going Self-Pay
This is a business comparison, not a clinical one. We line up the cash-pay and insurance models for regenerative medicine clinics across the dimensions that decide profit and growth: revenue per patient, marketing access, compliance burden, and more. The goal is to help you decide whether self-pay makes business sense before you commit. TLDR: For […]
Compliance in Digital Marketing The Regen Clinic Owner’s Guide to HIPAA
The standard digital marketing stack for a small medical practice includes the same technologies that produced nine-figure settlements for large health systems. Meta Pixel. Google Analytics. Contact forms. Chat widgets. When these are installed on a regenerative medicine clinic’s website, as they are on the majority of healthcare websites, they can transmit patient data to […]
States That Have Passed Stem Cell Marketing Laws in 2026: What Every Clinic Needs to Know
Most regenerative medicine clinic owners understand that federal law governs what they can say about stem cell therapies in their marketing. What far fewer understand is that several states have independently enacted their own laws governing stem cell practice and advertising, with mandatory disclaimer language and per-violation penalties that apply on top of the federal […]
How to Get More 5-Star Reviews Without Violating HIPAA or FTC Rules
Reviews matter for regenerative medicine clinics in ways they do not for most businesses. Patients check online reviews before choosing a provider. Reviews are a direct local ranking signal. A strong review profile is often the difference between a patient choosing your clinic or the one above you in the local pack. Most clinic owners […]
Why “Minimally Manipulated” Is Not a Marketing Strategy (And What Actually Is)
Walk into almost any regenerative medicine clinic website and the phrase shows up somewhere. “Minimally manipulated stem cells.” “We use only minimally manipulated tissue products.” “Our protocols use FDA-recognized minimally manipulated HCT/Ps.” Clinic owners use the phrase because someone in the industry told them it was the safe way to describe their products. It is […]
FDA Exosome Products Not Approved: What Your Clinic Can Still Say
The FDA has stated its position on exosome products plainly and repeatedly: no exosome products are currently approved for human use. Most clinic owners have heard this. Fewer understand what it actually means for their marketing. The result is two common mistakes. Either the clinic markets exosomes as if they were approved, or it avoids […]
FDA Warning Letters and Regenerative Medicine Clinics: What Every Clinic Owner Needs to Know
FDA warning letters to regenerative medicine clinics keep showing up in the public record. Most clinic owners read about them and assume the rules only apply to operations doing something extreme. The closer look tells a different story. The marketing behaviors that trigger most warning letters are the same ones that show up in ordinary […]
How to Market PRP Therapy When Google Bans Your Ads
If you run a regen clinic that offers PRP therapy, you have probably built an ad, set a budget, and watched Google reject it. Maybe more than once. Maybe your account got flagged. The problem is not random. Google explicitly named “platelet rich plasma” in its policy documentation alongside stem cell therapy and gene therapy. […]